Impact of fiberoptic bronchoscopy on systemic inflammatory markers and outcomes in neonatal patients with respiratory conditions

Fiberoptic bronchoscopy offers significant therapeutic benefits in neonatal respiratory care beyond airway management. The identified reduction in systemic inflammation and the novel association between SII and neonatal hyperbilirubinemia offer important insights for optimizing clinical practices and patient outcomes in neonatal respiratory medicine. Further research is warranted to validate these findings and explore their implications for individualized patient care.